192 related articles for article (PubMed ID: 37895229)
1. The Expression and Activation of the NF-κB Pathway Correlate with Methotrexate Resistance and Cell Proliferation in Acute Lymphoblastic Leukemia.
Canevarolo RR; Cury NM; Yunes JA
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895229
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.
Lo SZ; Steer JH; Joyce DA
Arthritis Res Ther; 2011 Feb; 13(1):R24. PubMed ID: 21324111
[TBL] [Abstract][Full Text] [Related]
3. Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Rots MG; Pieters R; Kaspers GJ; van Zantwijk CH; Noordhuis P; Mauritz R; Veerman AJ; Jansen G; Peters GJ
Blood; 1999 Feb; 93(3):1067-74. PubMed ID: 9920857
[TBL] [Abstract][Full Text] [Related]
4. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
Abedi M; Rahgozar S; Esmaeili A
Cancer Med; 2020 May; 9(10):3537-3550. PubMed ID: 32176452
[TBL] [Abstract][Full Text] [Related]
5. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.
Majumdar S; Aggarwal BB
J Immunol; 2001 Sep; 167(5):2911-20. PubMed ID: 11509639
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 induction.
Spurlock CF; Tossberg JT; Matlock BK; Olsen NJ; Aune TM
Arthritis Rheumatol; 2014 Nov; 66(11):2947-57. PubMed ID: 25077978
[TBL] [Abstract][Full Text] [Related]
8. Bioimaging analysis of nuclear factor-κB activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-α-stimulated changes to the microenvironment.
Tsai HJ; Kobayashi S; Izawa K; Ishida T; Watanabe T; Umezawa K; Lin SF; Tojo A
Cancer Sci; 2011 Nov; 102(11):2014-21. PubMed ID: 21777350
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
Parker A; Izmailova ES; Narang J; Badola S; Le T; Roubenoff R; Ginsburg GS; Maier A; Coblyn JS; Shadick NA; Weinblatt ME
J Rheumatol; 2007 Sep; 34(9):1817-22. PubMed ID: 17696278
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes.
Spurlock CF; Gass HM; Bryant CJ; Wells BC; Olsen NJ; Aune TM
Rheumatology (Oxford); 2015 Jan; 54(1):178-87. PubMed ID: 25118313
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.
King TJ; Georgiou KR; Cool JC; Scherer MA; Ang ES; Foster BK; Xu J; Xian CJ
Am J Pathol; 2012 Jul; 181(1):121-9. PubMed ID: 22642908
[TBL] [Abstract][Full Text] [Related]
13. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia.
Zhang H; Zhu L; He H; Zhu S; Zhang W; Liu X; Zhao X; Gao C; Mei M; Bao S; Zheng H
Mol Cancer; 2014 Jan; 13():5. PubMed ID: 24393203
[TBL] [Abstract][Full Text] [Related]
15. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
[TBL] [Abstract][Full Text] [Related]
16. The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells.
Wu W; Nie L; Zhang L; Li Y
Cell Mol Biol Lett; 2018; 23():37. PubMed ID: 30116272
[TBL] [Abstract][Full Text] [Related]
17. Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells.
Panetta JC; Sparreboom A; Pui CH; Relling MV; Evans WE
PLoS Comput Biol; 2010 Dec; 6(12):e1001019. PubMed ID: 21152005
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia.
Wojtuszkiewicz A; Peters GJ; van Woerden NL; Dubbelman B; Escherich G; Schmiegelow K; Sonneveld E; Pieters R; van de Ven PM; Jansen G; Assaraf YG; Kaspers GJ; Cloos J
J Hematol Oncol; 2015 May; 8():61. PubMed ID: 26022503
[TBL] [Abstract][Full Text] [Related]
19. Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.
Safa M; Tavasoli B; Manafi R; Kiani F; Kashiri M; Ebrahimi S; Kazemi A
Tumour Biol; 2015 May; 36(5):3919-30. PubMed ID: 25589462
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G
Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]